Navigation Links
eBioscience Corporation Acquires NatuTec GmbH
Date:9/8/2009

SAN DIEGO, Sept. 8 /PRNewswire/ -- eBioscience Corporation, a leading global provider of innovative, high-quality cell analysis reagents announced today the acquisition of NatuTec GmbH, a leading distributor of high-quality biological research reagents located in Frankfurt am Main, Germany.

"For the past 10 years, NatuTec has served as a leading European distributor of eBioscience products," said Todd R. Nelson, CEO of eBioscience. "The NatuTec acquisition provides eBioscience with the ability to streamline the distribution of our products by increasing customer service, technical support and customer fulfillment within the region and it strengthens the eBioscience brand within Europe," Nelson continued.

"We believe the business combination, which creates a direct commercial channel between eBioscience and its customers, will be of significant benefit through an enhanced ability to deliver cutting edge products to them faster and more reliably," said Eva Brigitte Leon, Managing Director of NatuTec.

About eBioscience Corporation

eBioscience provides innovative high quality reagents to academic and government researchers and pharmaceutical and biotech companies worldwide that empower the process of scientific discovery in the areas of stem cell biology, cellular immunity and oncology.

The company's extensive portfolio of more than 9000 leading edge cell analysis reagents and technologies, focused on flow cytometry and immunodetection, position eBioscience customers to be at the forefront of science. eBioscience is aligned with and responsive to the ever changing needs of its customers, making the company a preferred partner for scientific discovery.

Founded in 1999, eBioscience, a privately held company, is headquartered in San Diego, California and conducts business in more than 70 countries around the world. For more information about eBioscience, visit the company's web site at www.eBioscience.com or email corpcom@ebioscience.com.

About NatuTec GmbH

For nearly 15 years, NatuTec has been offering a high-quality, diverse selection of reagents to life science researchers. NatuTec's emphasis on supplying a broad array of immunology, molecular biology, toxicology and metabolism research products has enabled NatuTec to satisfy customers' demands in the ever-evolving area of scientific research. www.natutec.de


'/>"/>
SOURCE eBioscience Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. eBioscience Corporation Announced Today That James Glynn Has Been Appointed to Its Board of Directors, Effective April 15, 2008
2. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
3. Somanetics Corporation to Release Third Quarter 2009 Financial Results and Host Conference Call September 17, 2009
4. United Therapeutics Corporation Announces Stock Split To Be Effected as a Stock Dividend
5. ChemBridge Corporation and Collaborative Drug Discovery Announce Strategic Collaboration to Provide Diverse Chemical Libraries Together With Researchers Own Private Data
6. Environmental Tectonics Corporations BioMedical Systems Division Announces the Sale of a Monoplace Hyperbaric Chamber
7. Lawsuit Claims Celgene Corporation Misappropriated the Idea Behind its Multiple Myeloma Treatments
8. Massachusetts Technology Corporation Named to Inc. 5000 List of Fastest Growing Private Companies
9. Microfluidics International Corporation Announces Second Quarter 2009 Financial Results
10. Centage Corporation Announces Planning Maestro Business Performance Management Software for Mid-Market Enterprises
11. Volcano Corporation Presentation At Canaccord Adams Conference To Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... Village, CA (PRWEB) , ... August 17, 2017 ... ... technology for cancer research and personalized medicine, today announced the launch of a ... Kansas City, Missouri. The study’s goal is to evaluate the potential for early ...
(Date:8/16/2017)... ... 2017 , ... Today, 3Bar Biologics Inc ., the ... funding from an impressive group of investors, including Rev1 Ventures, Maumee Ventures, Ohio ... investment, 3Bar is broadening availability of its groundbreaking offering that uses naturally occurring ...
(Date:8/15/2017)... NC (PRWEB) , ... August 15, 2017 , ... ... 2017, celebrating 10 years of successes helping medical technology companies and inventors develop and ... to a renowned full-service national engineering firm with a portfolio of clients in the ...
(Date:8/15/2017)... , ... August 15, 2017 , ... The Conference ... on Immuno-Oncology 360° (IO360°) programming through a series of upcoming panels and events. The ... 7-9, 2018, at The Roosevelt Hotel in New York City. , “With our experience ...
Breaking Biology Technology:
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/28/2017)... , March 28, 2017 ... Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video ... and Region - Global Forecast to 2022", published by ... in 2016 and is projected to reach USD 75.64 ... 2017 and 2022. The base year considered for the ...
Breaking Biology News(10 mins):